AU5341790A - Purified ciliary neurotrophic factor - Google Patents

Purified ciliary neurotrophic factor

Info

Publication number
AU5341790A
AU5341790A AU53417/90A AU5341790A AU5341790A AU 5341790 A AU5341790 A AU 5341790A AU 53417/90 A AU53417/90 A AU 53417/90A AU 5341790 A AU5341790 A AU 5341790A AU 5341790 A AU5341790 A AU 5341790A
Authority
AU
Australia
Prior art keywords
cntf
neurons
highly purified
sds
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53417/90A
Other languages
English (en)
Inventor
Marston Manthorpe
Silvio Varon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU5341790A publication Critical patent/AU5341790A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AU53417/90A 1989-03-15 1990-03-14 Purified ciliary neurotrophic factor Abandoned AU5341790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32376189A 1989-03-15 1989-03-15
US323761 1989-03-15

Publications (1)

Publication Number Publication Date
AU5341790A true AU5341790A (en) 1990-10-09

Family

ID=23260603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53417/90A Abandoned AU5341790A (en) 1989-03-15 1990-03-14 Purified ciliary neurotrophic factor

Country Status (5)

Country Link
EP (1) EP0463082A1 (fr)
JP (1) JPH04503811A (fr)
AU (1) AU5341790A (fr)
CA (1) CA2047718A1 (fr)
WO (1) WO1990010647A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642858B2 (en) * 1989-01-05 1993-11-04 Regeneron Pharmaceuticals, Inc. Purified ciliary neurotrophic factor

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405835B (de) * 1989-01-05 1999-11-25 Synergen Inc Aufgereinigter ziliärer neurotropher faktor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
GR900100691A (el) * 1989-09-15 1992-01-20 Max Planck Gesellschaft Νευροτροφικός παράγοντας ακτινωτού.
CA2113815A1 (fr) * 1991-07-23 1993-02-04 Franklin D. Collins Purification du facteur neurotrophique ciliaire recombinant, facteur neurotrophique ciliaire a extremite c-terminale tronquee et methodes de traitement des lesions neurales peripheriques
US5593857A (en) * 1991-08-23 1997-01-14 Scios Inc. Production of homogeneous truncated CNTF
ES2422881T3 (es) * 2002-06-20 2013-09-16 Augustinus Bader Uso de eritropoyetina para la regeneración de tejido in vivo
US20050222101A1 (en) * 2004-03-30 2005-10-06 Jeffrey Hutterer Method and composition for treatment of skin conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128449A (en) * 1988-07-05 1992-07-07 The University Of Tennessee Research Corporation Polypeptide and a method for its production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642858B2 (en) * 1989-01-05 1993-11-04 Regeneron Pharmaceuticals, Inc. Purified ciliary neurotrophic factor

Also Published As

Publication number Publication date
WO1990010647A1 (fr) 1990-09-20
EP0463082A1 (fr) 1992-01-02
CA2047718A1 (fr) 1990-09-16
JPH04503811A (ja) 1992-07-09

Similar Documents

Publication Publication Date Title
Acheson et al. Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF
Manthorpe et al. Purification of adult rat sciatic nerve ciliary neuronotrophic factor
Sendtner et al. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration.
Brenneman et al. A femtomolar-acting neuroprotective peptide.
JP2798413B2 (ja) ヒト神経成長因子
CA2132954C (fr) Facteurs neurotropes ciliaires modifies
Barbin et al. Purification of the chick eye ciliary neuronotrophic factor
Azmitia et al. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor
Petrova et al. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons
US5166317A (en) Neurotrophic factor
EP0410246B1 (fr) Peptides dérivés de l'érythropoiétine (EPO) et anticorps dirigés contre eux
EP0448707B1 (fr) Bacteries contenant des vecteurs d'expression codant pour le facteur NEUROTROPHIQUE CILIAIRE (h-CNTF), leur utilisation pour la production d'h-CNTF, anticorps dirigés contre l'h-CNTF et l'utilisation de l'h-CNTF pour des traitements médicaux.
US5767240A (en) Activity-dependent neurotrophic factor
KR970700438A (ko) 마크로파지 염증성 단백질-3,-4 및 -1감마(MACROPHAGE INFLAMMATORY PROTEINS -3,-4 AND -1sg(g))
EP0474979A1 (fr) Séquence du gène du facteur neurotrohpique liant l'héparine
AU5341790A (en) Purified ciliary neurotrophic factor
CZ470790A3 (cs) Čištěná polypeptidová sloučenina
US20040077545A1 (en) Synthetic peptide for neurological disorders
US6841531B2 (en) Methods and use of motoneuronotrophic factors
CA2354378A1 (fr) Cofacteurs pour facteurs trophiques et procedes d'utilisation
EP0261403A3 (fr) Polypeptide de rhinovirus souche HRV89, et molécule d'ADN qui l'encode
EP0458673B1 (fr) Facteur inhibiteur de la croissance et ADNc codant pour le facteur inhibiteur de la croissance
EP0241136A2 (fr) Facteur de croissance humaine classe 1, liant l'héparine
EP0526883B1 (fr) Protéine chondromodulin-II
Hu et al. Increase of ciliary neurotrophic factor (CNTF) in the ischemic rat· brain as determined by a sensitive enzyme-linked immunoassay